139 related articles for article (PubMed ID: 36897628)
1. Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.
Bacchus MK; Anderson DS; Berko ER; States LJ; Bagatell R; Hopkins SE; Batra V
J Pediatr Hematol Oncol; 2023 Apr; 45(3):152-154. PubMed ID: 36897628
[TBL] [Abstract][Full Text] [Related]
2. Treatment and revaccination of children with paraneoplastic opsoclonus-myoclonus-ataxia syndrome and neuroblastoma: The Memorial Sloan Kettering experience.
Patel A; Fischer C; Lin YC; Basu EM; Kushner BH; De Braganca K; Khakoo Y
Pediatr Blood Cancer; 2020 Aug; 67(8):e28319. PubMed ID: 32543116
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
[TBL] [Abstract][Full Text] [Related]
4. Surgical considerations for neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: a series of 14 patients from a single institution.
Johnston WR; Hwang R; Mattei P
Pediatr Surg Int; 2022 Feb; 38(2):249-255. PubMed ID: 34549330
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Opsoclonus-Myoclonus-Ataxia Syndrome in Children: An International Perspective.
Rossor T; Yeh EA; Khakoo Y; Angelini P; Hemingway C; Irani SR; Schleiermacher G; Santosh P; Lotze T; Dale RC; Deiva K; Hero B; Klein A; de Alarcon P; Gorman MP; Mitchell WG; Lim M;
Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35260471
[TBL] [Abstract][Full Text] [Related]
6. Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
Prabaharan H; Chandrasekaran S; Shetty N; Nayak K P
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417946
[TBL] [Abstract][Full Text] [Related]
7. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
8. Opsoclonus-myoclonus-ataxia syndrome in children.
Bhatia P; Heim J; Cornejo P; Kane L; Santiago J; Kruer MC
J Neurol; 2022 Feb; 269(2):750-757. PubMed ID: 33779841
[TBL] [Abstract][Full Text] [Related]
9. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
10. Five Years Follow-up of Opsoclonus-Myoclonus-Ataxia Syndrome-Associated Neurogenic Tumors in Children.
Aktekin EH; Gezer HÖ; Yazıcı N; Erol İ; Erbay A; Sarıalioğlu F
Neuropediatrics; 2024 Feb; 55(1):57-62. PubMed ID: 37019145
[TBL] [Abstract][Full Text] [Related]
11. Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
Deniz A; Alikılıç D; Öztürk M; Karaca Ö; Güngör M; Kara B
J AAPOS; 2023 Apr; 27(2):110-112. PubMed ID: 36736453
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma-associated Opsoclonous Myoclonous Ataxia Syndrome: Profile and Outcome Report on 15 Egyptian Patients.
Elzomor H; El Menawi S; Elawady H; Elkinaai N; Elshafie M; Refaat A; Ghareeb H; Fawzy M
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e194-e199. PubMed ID: 35462382
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome.
Greensher JE; Louie J; Fish JD
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28926689
[TBL] [Abstract][Full Text] [Related]
14. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
[TBL] [Abstract][Full Text] [Related]
15. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis.
Gurkas E; Gucuyener K; Yılmaz U; Havalı C; Demir E
Pediatr Int; 2014 Dec; 56(6):e86-e87. PubMed ID: 25521990
[TBL] [Abstract][Full Text] [Related]
16. Update on pediatric opsoclonus myoclonus syndrome.
Hero B; Schleiermacher G
Neuropediatrics; 2013 Dec; 44(6):324-9. PubMed ID: 24203854
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic values of
Kumar R; Vankadari K; Mittal BR; Bansal D; Trehan A; Sahu JK; Sankhyan N
Eur Radiol; 2021 Jul; 31(7):4587-4594. PubMed ID: 33409780
[TBL] [Abstract][Full Text] [Related]
18. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma presenting as opsoclonus-myoclonus: A series of six cases and review of literature.
Meena JP; Seth R; Chakrabarty B; Gulati S; Agrawala S; Naranje P
J Pediatr Neurosci; 2016; 11(4):373-377. PubMed ID: 28217170
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome: Role of Chemotherapy in the Management: Experience From a Tertiary Care Center in a Resource-limited Setting.
Anand S; Agarwala S; Jain V; Bakhshi S; Dhua A; Gulati S; Seth R; Srinivas M; Jana M; Kandasamy D; Bhatnagar V
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e924-e929. PubMed ID: 33769388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
